Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

May 22 • 04:00PM ET

8.67

-0.23 -2.58 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CABA RNAC CRBU FATE SANA

| Held by: VTI VXF IBB SCHA DWAS SURI IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.28	Insider Own	37.95%	Shs Outstand	60.53M	Perf Week	-8.64%
Market Cap	527.09M	Forward P/E	-	EPS next Y	-2.94	Insider Trans	1.06%	Shs Float	37.73M	Perf Month	-3.13%
Enterprise Value	324.40M	PEG	-	EPS next Q	-0.68	Inst Own	42.34%	Short Float	13.68%	Perf Quarter	9.61%
Income	-156.40M	P/S	-	EPS this Y	21.29%	Inst Trans	1.12%	Short Ratio	5.69	Perf Half Y	5.35%
Sales	0.00M	P/B	2.68	EPS next Y	-2.68%	ROA	-60.42%	Short Interest	5.16M	Perf YTD	-7.77%
Book/sh	3.23	P/C	2.23	EPS next 5Y	13.65%	ROE	-74.55%	52W High	13.67 -36.58%	Perf Year	251.01%
Cash/sh	3.89	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-68.79%	52W Low	2.19 295.89%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.80% 7.48%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	2.58%	Oper. Margin	-	ATR (14)	0.75	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.15	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.15	EPS Q/Q	36.35%	SMA20	-6.30%	Beta	2.05	Target Price	30.40
Payout	-	Debt/Eq	0.17	Sales Q/Q	-	SMA50	-4.30%	Rel Volume	0.55	Prev Close	8.90
Employees	130	LT Debt/Eq	0.16	Earnings	May 12 AMC	SMA200	16.36%	Avg Volume	907.65K	Price	8.67
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.20% -	Trades		Volume	498,595	Change	-2.58%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)